February is the first day of spring and it is still warm. The annual fundus event – 2019 China Fundus Forum and International Retina Symposium (Retina China 2019) was grandly held in Shanghai Songjiang District Fuyue Hotel, where elites gathered, big names gathered, an unprecedented event, and Big Vision was honored to be invited to participate and meet with new friends and old friends in Shanghai.
This is the fourth consecutive year that Big Vision has participated in the Fundus Forum. The application of artificial intelligence in the field of ophthalmology has been increasingly accepted and recognized, which is inseparable from the persistence and efforts of medical imaging artificial intelligence pioneers like Big Vision. This time, Big Vision showcased MIAS, a precise and convenient OCT multimodal ophthalmic image assisted diagnosis system, and MIPA, an image assist and analysis software for ophthalmic disease research. Many domestic well-known ophthalmology medical institutions director experts came to the Big Vision booth to talk about the clinical application of artificial intelligence in the diagnosis and treatment of ophthalmic diseases.
The MIAS fun quiz activity organized by Big Vision also attracted many attendees, and the booth was packed with people answering the questions enthusiastically.
MIAS is the first software system in China based on image processing and artificial intelligence analysis algorithm to store, process and analyze optical coherence tomography (OCT) and fundus color photography dual-modality ophthalmology images, integrating automatic identification, labeling and quantitative analysis of lesion areas, with multiple storage and operation modes in the cloud and stand-alone, and has been awarded the CFDA Class II medical device registration certificate.
MIPA is a medical image assistant and analysis software specially developed by Big Vision for ophthalmic disease research, integrating disease diagnosis and analysis, disease growth prediction and efficacy assessment, etc. It has international leading algorithms, automatic and accurate stratification, multiple drawing methods of 3D reconstruction, various interaction methods, flexible architecture, and can be customized for new module development, and has been used in many famous hospitals for clinical It has been clinically tested in many famous hospitals and is highly praised.
In the future, the people of Big Vision will continue to uphold the spirit of “dream, passion, and practical work” and take “early detection of every pair of eyes with problems, and give the best treatment plan” as the mission to forge ahead and use artificial intelligence to empower ophthalmology treatment and create more value for society.
No comments yet.